Lars Petersen, Fujifilm Diosynth CEO
November 9, 2023 12:33 PM ESTUpdated November 10, 10:12 AM
Manufacturing

Com­mer­cial-stage man­u­fac­tur­ing key for CD­MOs as biotech fund­ing pull­back con­tin­ues, Fu­ji­film Diosynth CEO says

Anna Brown

News Reporter

On the back of re­duced fund­ing in ear­ly clin­i­cal-stage as­sets, CD­MOs need to strength­en their com­mer­cial, large-scale man­u­fac­tur­ing ca­pa­bil­i­ties for 2024 in what looks like …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

NewAms­ter­dam aces Phase 3 tri­al, but in­vestors are skep­ti­cal

Post-Hoc: RFK vs. Vivek, and the fu­ture of US drug pol­i­cy

FDA up­dates la­bel of 33-year-old can­cer drug with new dose and warn­ing

Pfiz­er part­ners with two more Flag­ship biotechs on obe­si­ty, can­cer

When gen­er­a­tive AI meets the FDA: First dig­i­tal health ad­comm kicks off dis­cus­sion

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times